Clinical characteristics and risk factors for shock and death from E. coli bacteremia in pediatric hematological patients

• Published in: Journal of infection in developing countries Vol. 13; no. 5; pp. 365 - 373
• Main Authors: Wang, Haichen, Liu, Jianling, Huang, Ziyan, Tao, Xiaoyan, Li, Jun, Hu, Yongmei, Dou, Qingya, Zou, Mingxiang, Yan, Qun, Liu, Wen' En
• Format: Journal Article
• Language: English
• Published: Italy Journal of Infection in Developing Countries 31.05.2019
• Subjects: E coli; Hematology; Laboratories; Mortality; Pediatrics; Risk factors; hematological disorders; mortality; risk factors; Escherichia coli; shock; bacteremia
• ISSN: 1972-2680; 2036-6590; 1972-2680
• DOI: 10.3855/jidc.11099

The aim of our study was to evaluate the epidemiology, clinical features and risk factors for shock and mortality from Escherichia coli bacteremia among children and adolescents with hematological disorders. A retrospective observational study of E. coli bacteremia in the hematology department at Xiangya Hospital from January 2013 to June 2018 was conducted. Clinical characteristics, laboratory results and antimicrobial susceptibility were analysed. Risk factors for shock and mortality were also investigated. Of the 45 strains of E. coli, 73.3% were multidrug-resistant (MDR). Septic shock was observed in 51.1% of patients, and the 30-day all-cause mortality was 22.2%. The risk factors associated with shock were an elevated red blood cell distribution (RDW) value when bloodstream infections (BSIs) occurred (> 15%, OR, 6.840; 95% CI, 1.571 - 29.788) and a lower WBC count (< 300/mm3, OR, 6.761; 95% CI, 1.383 - 33.044). Multivariate analysis showed that only an elevated D-dimer level (> 0.5 mg/L, OR 12.250, 95% CI 1.268 - 118.361) was a risk factor for 30-day mortality. Furthermore, we observed decreases for RDW changes at two time points (neutropenia and BSIs occurred) in the non-shock group and survival group. MDR infections from E. coli bacteremia were common in pediatric hematological patients. In our setting, the laboratory results may serve as a clue for physicians to distinguish patients at higher risk for shock and mortality. Furthermore, RDW could be used as a biomarker to elucidate potential disorders in hematological patients.